Published in J Virol on June 01, 1990
Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57
Visualization and characterization of tobacco mosaic virus movement protein binding to single-stranded nucleic acids. Plant Cell (1992) 2.53
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis. Nat Biotechnol (2008) 2.52
Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol (2003) 2.20
An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. J Virol (2004) 1.99
trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol (1991) 1.79
The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol (1993) 1.62
Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol (1998) 1.51
Editing on the genomic RNA of human hepatitis delta virus. J Virol (1992) 1.48
Specific HDV RNA-templated transcription by pol II in vitro. RNA (2000) 1.36
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest (2003) 1.33
Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J Virol (2002) 1.29
Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome. J Virol (2001) 1.21
Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus. J Virol (1993) 1.21
In vivo RNA-directed transcription, with template switching, by a mammalian RNA polymerase. EMBO J (2002) 1.16
Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. J Virol (1994) 1.15
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J Virol (2002) 1.13
Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol (1998) 1.12
Development of a novel system to study hepatitis delta virus genome replication. J Virol (2005) 1.09
Initiation of hepatitis delta virus genome replication. J Virol (1998) 1.06
Precisely full length, circularizable, complementary RNA: an infectious form of potato spindle tuber viroid. Proc Natl Acad Sci U S A (1998) 0.98
Prominent polypurine and polypyrimidine tracts in plant viroids and in RNA of the human hepatitis delta agent. Nucleic Acids Res (1993) 0.97
Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: different roles for the small and large delta antigens. J Virol (1994) 0.95
Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev (1993) 0.94
Features affecting the ability of hepatitis delta virus RNAs to initiate RNA-directed RNA synthesis. J Virol (2004) 0.92
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options. Nat Rev Gastroenterol Hepatol (2016) 0.82
RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells. J Virol (2005) 0.82
Molecular and clinical aspects of hepatitis D virus infections. World J Virol (2012) 0.81
A novel quantitative microarray antibody capture (Q-MAC) assay identifies an extremely high HDV prevalence amongst HBV infected Mongolians. Hepatology (2016) 0.79
Pathogen receptor discovery with a microfluidic human membrane protein array. Proc Natl Acad Sci U S A (2016) 0.75
Construction and eukaryotic expression of recombinant large hepatitis delta antigen. Rep Biochem Mol Biol (2013) 0.75
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen. Viruses (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol (1972) 5.93
Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
A replication cycle for viroids and other small infectious RNA's. Science (1984) 5.18
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05
Mechanisms of spontaneous and induced frameshift mutation in bacteriophage T4. Genetics (1985) 3.83
The delta agent. Hepatology (1983) 3.72
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81
An efficient method for introducing macromolecules into living cells. J Cell Biol (1985) 2.60
Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36
Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol (1989) 1.78
Reversible cleavage and ligation of hepatitis delta virus RNA. Science (1989) 1.59
Delivery of macromolecules into cells expressing a viral membrane fusion protein. Methods Cell Biol (1989) 1.31
Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase. Biochim Biophys Acta (1976) 12.73
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell (1996) 10.49
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Analysis of unintegrated avian RNA tumor virus double-stranded DNA intermediates. J Virol (1978) 7.06
The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med (1990) 6.94
Nanoscale magnetic sensing with an individual electronic spin in diamond. Nature (2008) 6.58
Coherent manipulation of coupled electron spins in semiconductor quantum dots. Science (2005) 6.39
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell (1994) 5.65
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14
Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc Natl Acad Sci U S A (1982) 4.69
Site on the RNA of an avian sarcoma virus at which primer is bound. J Virol (1975) 4.60
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Analysis of integrated avian RNA tumor virus DNA in transformed chicken, duck and quail fibroblasts. J Virol (1979) 4.34
The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol (2005) 4.19
Water-borne outbreak of campylobacter gastroenteritis. Lancet (1983) 3.97
Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer. J Virol (1974) 3.90
Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol (1996) 3.77
A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature (1992) 3.71
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67
Genetic lesion in homozygous alpha thalassaemia (hydrops fetalis). Nature (1974) 3.58
Purification and characterization of the deoxyribonucleic acid polymerase associated with Rous sarcoma virus. Biochemistry (1972) 3.53
Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest (1985) 3.49
Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene (2000) 3.44
The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol (1988) 3.43
Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A (1978) 3.42
Coherent dynamics of coupled electron and nuclear spin qubits in diamond. Science (2006) 3.39
An analysis of the role of tRNA species as primers for the transcription into DNA of RNA tumor virus genomes. Biochim Biophys Acta (1977) 3.38
Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J Virol (1983) 3.35
GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol (1995) 3.34
RNA-directed DNA polymerase of Rous sarcoma virus: initiation of synthesis with 70 S viral RNA as template. J Mol Biol (1973) 3.32
Estimation in a Cox proportional hazards cure model. Biometrics (2000) 3.26
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell (1998) 3.25
Intermediates in influenza induced membrane fusion. EMBO J (1990) 3.24
Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J Bacteriol (1994) 3.12
Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science (2001) 3.11
Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature (1989) 2.83
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence. J Biol Chem (1989) 2.82
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A (1995) 2.80
COVER (cover of vaccination evaluated rapidly): description of the England and Wales scheme. Public Health (1989) 2.77
Transcription of DNA from the 70S RNA of Rous sarcoma virus. II. Structure of a 4S RNA primer. J Virol (1974) 2.73
Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry (1990) 2.73
Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A (1985) 2.59
ADAMs: focus on the protease domain. Curr Opin Cell Biol (1998) 2.42
An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol (1996) 2.38
Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys (1995) 2.35
Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology (2001) 2.34
A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell (1999) 2.34
A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem (1993) 2.33
Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS (1998) 2.33
Mouse egg integrin alpha 6 beta 1 functions as a sperm receptor. Cell (1995) 2.32
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Identification of a prenylation site in delta virus large antigen. Science (1992) 2.29
Effects of organic acids on ion uptake and retention in barley roots. Plant Physiol (1970) 2.25
Retroid virus genome replication. Adv Virus Res (1987) 2.23
Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J Cell Biol (1997) 2.21
Isolation of hen oviduct ovalbumin and rat live albumin polysomes by indirect immunoprecipitation. J Biol Chem (1974) 2.20
The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J Virol (1994) 2.17
Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A (1985) 2.16
Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain. Lancet (1984) 2.16
Ribonucleic acid directed deoxyribonucleic acid synthesis by the purified deoxyribonucleic acid polymerase of Rous sarcoma virus. Characterization of the enzymatic product. Biochemistry (1972) 2.13
Synthesis of rat liver albumin in a rabbit reticulocyte cell-free protein-synthesizing system. J Biol Chem (1973) 2.13
The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J Cell Biol (2000) 2.13
Glucocorticoid-mediated induction of alpha 1-acid glycoprotein: evidence for hormone-regulated RNA processing. Proc Natl Acad Sci U S A (1984) 2.13
Rat apolipoprotein E mRNA. Cloning and sequencing of double-stranded cDNA. J Biol Chem (1983) 2.12
Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J Virol (1995) 2.10
Hyperalgesic responses in methadone maintenance patients. Pain (2001) 2.09
A randomized clinical trial of anticaries therapies targeted according to risk assessment (caries management by risk assessment). Caries Res (2012) 2.08
Tumor virus ribonucleic acid directed deoxyribonucleic acid synthesis: nucleotide sequence at the 5' terminus of nascent deoxyribonucleic acid. Biochemistry (1974) 2.06
Synthesis of a deoxyribonucleic acid sequence complementary to ovalbumin messenger ribonucleic acid and quantification of ovalbumin genes. J Biol Chem (1973) 2.05
Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract (2002) 2.00
ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol (1995) 2.00
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J Virol (1990) 2.00
Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol (1993) 1.98
Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J Virol (1990) 1.97
Deletion of alpha-globin genes in haemoglobin-H disease demonstrates multiple alpha-globin structural loci. Nature (1975) 1.95
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol (2001) 1.95
Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development (1993) 1.94
Tetanus in England and Wales, 1984-2000. Epidemiol Infect (2003) 1.93
Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J Virol (1994) 1.93
Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J Virol (1990) 1.91
Proteolytic processing of a protein involved in sperm-egg fusion correlates with acquisition of fertilization competence. J Cell Biol (1990) 1.90
Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. Am J Epidemiol (1989) 1.90
Initiation of plus-strand DNA synthesis during reverse transcription of an avian retrovirus genome. J Virol (1984) 1.87
Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology (1988) 1.85
How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat Res (1990) 1.83
Relating structure to function in the hepatitis delta virus antigen. J Virol (1993) 1.82
Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. J Natl Cancer Inst (2000) 1.80
trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol (1991) 1.79
GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J Cell Biol (1993) 1.78
Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem (1984) 1.78
UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiol Infect (2000) 1.77
Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A (1994) 1.76
Epidermal growth factor: chemical and biological characterization. Recent Prog Horm Res (1974) 1.76
Specificity of initiation of plus-strand DNA by Rous sarcoma virus. J Virol (1984) 1.75
ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol (1995) 1.73
Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest (1995) 1.73
Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect (2010) 1.72